Dermapharm Holding SE
XBER:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
XBER:DMP
|
DE |
|
S
|
Sumitomo Osaka Cement Co Ltd
XBER:SU2
|
JP |
|
Zymeworks Inc
NASDAQ:ZYME
|
US |
|
Office Properties Income Trust
NASDAQ:OPI
|
US |
|
Q
|
Qt Group Oyj
F:2QT
|
FI |
|
GEM Co Ltd
F:3730
|
CN |
|
C
|
CNO Financial Group Inc
XBER:COS
|
US |
|
N
|
Nippon Steel Corp
XBER:NPS
|
JP |
|
Interpump Group SpA
OTC:IPGLF
|
IT |
|
Laboratorios Farmaceuticos ROVI SA
F:41L
|
ES |
|
Laboratorios Farmaceuticos ROVI SA
OTC:LABFF
|
ES |
|
F
|
FMC Corp
XMUN:FMQ
|
US |
|
DMG Mori Co Ltd
F:0MO
|
JP |
|
Asmallworld AG
F:1Q7
|
CH |
|
P
|
Pandora A/S
OTC:PANDY
|
DK |
|
V
|
VMware Inc
F:BZF1
|
US |
|
N
|
Nippon Steel Corp
F:NPS
|
JP |
|
Interpump Group SpA
F:8IG
|
IT |
|
R
|
Raiffeisen Bank International AG
VSE:RBI
|
AT |
|
K
|
Kalvista Pharmaceuticals Inc
F:4XC1
|
US |
|
E
|
Evonik Industries AG
MIL:EVK
|
DE |
|
A
|
Asta Co Ltd
KOSDAQ:246720
|
KR |
|
Compania de Distribucion Integral Logista Holdings SA
MAD:LOG
|
ES |
|
R
|
Raiffeisen Bank International AG
F:RAW0
|
AT |
Wall St Price Targets
DMP Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for DMP is 49.17 EUR with a low forecast of 42.84 EUR and a high forecast of 60.73 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMP's stock price target?
Price Target
49.17
EUR
According to Wall Street analysts, the average 1-year price target for DMP is 49.17 EUR with a low forecast of 42.84 EUR and a high forecast of 60.73 EUR.
What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Dermapharm Holding SE?
Projected CAGR
4%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
6%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 8%.
